Clinical Trial Update: Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 2 trial evaluating surufatinib in combination with gemcitabine and nab-paclitaxel as peri-operative treatment fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemcitabine (Gemcitabine)
• Surufatinib (Surufatinib)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING